SlideShare une entreprise Scribd logo
1  sur  14
NEURO-HUMORAL TRANSMISSION
PRESENTED BY:
HEENA PARVEEN,
M.PHARMACOLOGY,
ASST.PROFESSOR.
NEURO-HUMORAL TRANSMISSION
Neurohumoral transmission implies that nerves transmit their message
across synapses and neuro-effector junctions by the release of humoral
chemical) messengers.
Junctional transmission was thought to be electrical (it does occur in
some lower animals and probably in certain areas of mammalian
brain) but observations at the turn of last century prompted Elliott
(1905) to suggest that sympathetic nerves functioned by the release of
an adrenaline-like substance, and Dixon (1907) to propose that vagus
released a muscarine like chemical.
Otto Loewi (1921) provided direct proof of humoral transmission by
perfusing two frog hearts in series. Stimulation of vagus nerve of the
first heart caused arrest of both.
To be considered as a postjunctionally acting neurohumoral transmitter a
substance must fulfill the following criteria:
It should be present in the presympathetic neuron (usually along with
enzymes synthesizing it).
It should be released in the medium following nerve stimulation.
Its application should produce responses identical to those produced by
nerve stimulation.
Its effects should be antagonized or potentiated by other substances
which similarlv alter effects of nerve stimulation.
Steps in neurohumoral transmission:
1. lmpulse conduction :
The resting transmembrane potential (-70 mV) is established by high K*
permeability of axonal membrane and high axoplasmic concentration
of this ion coupled with low Na* permeabilitv and its active extrusion
from the neuron stimulation or arrival of an electrical impulse causes a
sudden increase in Na* conductance depolarization and overshoot
(reverse polarization, inside becoming 20 mV positive); K* ions then
move out in the direction of their concentration gradient &
repolarisation occurs.
Ionic distribution is normalized during the refractory period by the
activation of Na* K* pump.
The action potential (AP) thus generated sets up local circuit currents
which activate ionic channels at the next excitable part of the
membrane (next node of Ranvier in myelinated nerve) and the AP is
propagated without decrement.
2.Transmitter release:
The transmitter (excitory or inhibitory) is stored in prejunctional nerve
endings within sympathetic vesicles.
Nerve impulse promotes fusion of vesicular and neuronal membranes
through Ca+2 entry which fluidizes membranes.
All contents of the vesicle transmitter, enzymes and other proteins) are
extruded (exocytosis) in the junctional cleft.
The release process can be modulated by the transmitter itself and by
other agents through activation of specific receptors located on the
prejunctional membrane.
Example :
Noradrenaline (NA) release is inhibited by NA (receptor), dopamine,
adenosine, prostaglandins and enkephalins while isoprenaline
(B2 receptor) and angiotensin AT1 receptor) increase NA release.
3.Transmitter action on postiunctional membrane:
The released transmitter combines with specific receptors on the
postjunctional membrane and depending on its nature induces an
excitatory postsynaptic potential (EPSP) or an inhibitory postsynaptic
potential (IPSP).
EPSP :
Increase in permeability to all cations -> Na* or Ca2* influx (through
fast or slow channels) causes depolarization followed by K* efflux.
These ionic movements are passive as the flow is down the
concentration gradients.
IPSP : Increase in permeability to smaller ions, i.e. K* and Cl- (hydrated
K+ ion is smaller than hydrated Na* ion) only, so that K* moves out
and Cl- moves in (in the direction of their concentration gradients)
resulting in hyperpolarisation.
4. Postjunctional activity:
A suprathreshold EPSP generates a propagated postjunctional AP which
results in nerve impulse (in neurone), contraction (in muscle) or
secretion (in gland).
An IPSP stabilizes the postjunctional membrane and resists depolarizing
stimuli.
5. Termination of transmitter action :
Following its combination with the receptor, the transmitter is either
locally degraded (e.g. ACh) or is taken back into the prejunctional
neurone by active uptake or diffuses away (e.g. NA,GABA).
Specific carrier proteins like norepinephrine transporter (NET),
dopamine transporter (DAT), serotonin transporter (SERT) are
expressed on the axonal membrane for this purpose. The rate of
termination of transmitter action governs the rate at which responses
can be transmitted across a junction (1 to 1000/sec).
Co-Transmission
It has now become apparent that the classical one neuron one
transmitter' model is an over simplification. Most peripheral and
central neurons have been shown to release more than one active
substance when stimulated.
In the ANS, besides the primary transmitters ACh and NA, neurons have
been found to elaborate purines (ATP, adenosine), peptides
(vasoactive intestinal peptide or VIP, neuropeptide-Y or NPY,
substance P, enkephalins, somatostatin, etc.), nitric oxide and
prostaglandins as co-transmitters.
In most autonomic cholinergic neurons VIP is associated with ACh,
while ATP is associated with both Ach and NA.
Vascular adrenergic nerves contain NPY which causes long lasting
vasoconstriction.
The co-transmitter is stored in the same neuron but in distinct synaptic
vesicles or locations.
However, ATP is stored with NA in the same vesicle. On being released
by the nerve impulse it may serve to regulate the presynaptic release
of the primary transmitter and,/or postsynaptic sensitivity to it
(neuromodulator role).
The co-transmitter may also serve as an alternative transmitter in its own
right and/or exert a trophic influence on the sympathetic structures
Nonadrenergic, noncholinergic (NANC) transmission has been
demonstrated in the autonomic innervation of the gut, vas deferens,
urinary tract, salivary glands and certain blood vessels, where nerve
stimulation is able to evoke limited responses even in the presence of
total adrenergic and cholinergic blockade.
For example, it has been shown that stimulation of sympathetic nerve to
guinea pig vas deferens elicits a biphasic contractile response, the
initial short-lasting phase of which is mediated by ATP (through P2
receptors) and the second longer lasting phase by NA (through u1
receptors).
Many anomalous findings have been explained by the revelation of
cotransmission.
TH9K UH!

Contenu connexe

Tendances

Neurohumoral transmission in ans
Neurohumoral transmission  in  ansNeurohumoral transmission  in  ans
Neurohumoral transmission in ansLalitaShahgond
 
Expt 10 Effects of skeletal muscle relaxants using rota-rod apparatus
Expt 10  Effects of skeletal muscle relaxants using rota-rod apparatusExpt 10  Effects of skeletal muscle relaxants using rota-rod apparatus
Expt 10 Effects of skeletal muscle relaxants using rota-rod apparatusMirza Anwar Baig
 
Neurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemNeurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemSONALPANDE5
 
Neurohumoral transmission in ans final fully1cl f
Neurohumoral transmission in ans final fully1cl fNeurohumoral transmission in ans final fully1cl f
Neurohumoral transmission in ans final fully1cl frahulsharma3589
 
Physiological salt solution - PSS
Physiological salt solution - PSSPhysiological salt solution - PSS
Physiological salt solution - PSSJervinM
 
Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology. Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology. Javeria Fateh
 
Expt 12 Anticonvulsant effect of drugs by MES and PTZ method
Expt 12 Anticonvulsant effect of drugs by MES and PTZ methodExpt 12 Anticonvulsant effect of drugs by MES and PTZ method
Expt 12 Anticonvulsant effect of drugs by MES and PTZ methodMirza Anwar Baig
 
Expt. 1 Introduction to in vitro pharmacology and physiological salt solutions
Expt. 1 Introduction to in vitro pharmacology and physiological salt solutionsExpt. 1 Introduction to in vitro pharmacology and physiological salt solutions
Expt. 1 Introduction to in vitro pharmacology and physiological salt solutionsVISHALJADHAV100
 
Effect of drugs on frog's heart perfusion
Effect of drugs on frog's heart perfusionEffect of drugs on frog's heart perfusion
Effect of drugs on frog's heart perfusionkopalsharma85
 
Pharmacology (effects of drugs on the ciliary motility of forg oesophagus)
Pharmacology (effects of drugs on the ciliary motility of forg oesophagus)Pharmacology (effects of drugs on the ciliary motility of forg oesophagus)
Pharmacology (effects of drugs on the ciliary motility of forg oesophagus)Osama Al-Zahrani
 
Commonly used instruments in Experimental Pharmacology
Commonly used instruments in Experimental Pharmacology Commonly used instruments in Experimental Pharmacology
Commonly used instruments in Experimental Pharmacology Dr.Arka Mondal
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.pptramchoure90
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DKameshwaran Sugavanam
 
Parasympathomimetics medicinal chemistry b. pharm.
Parasympathomimetics   medicinal chemistry    b. pharm. Parasympathomimetics   medicinal chemistry    b. pharm.
Parasympathomimetics medicinal chemistry b. pharm. AZCPh
 
Neurohumoral transission in CNS
Neurohumoral transission in CNSNeurohumoral transission in CNS
Neurohumoral transission in CNSDekollu Suku
 
SUBSTANCE P by RAGHUL PHARMACIST.
SUBSTANCE P by RAGHUL PHARMACIST.SUBSTANCE P by RAGHUL PHARMACIST.
SUBSTANCE P by RAGHUL PHARMACIST.Raghul Kalam
 

Tendances (20)

Neurohumoral transmission in ans
Neurohumoral transmission  in  ansNeurohumoral transmission  in  ans
Neurohumoral transmission in ans
 
2.2.1 neurohumoral transmission
2.2.1 neurohumoral transmission2.2.1 neurohumoral transmission
2.2.1 neurohumoral transmission
 
Expt 10 Effects of skeletal muscle relaxants using rota-rod apparatus
Expt 10  Effects of skeletal muscle relaxants using rota-rod apparatusExpt 10  Effects of skeletal muscle relaxants using rota-rod apparatus
Expt 10 Effects of skeletal muscle relaxants using rota-rod apparatus
 
Neurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous systemNeurohumoral Transmission in central nervous system
Neurohumoral Transmission in central nervous system
 
Neurohumoral transmission in ans final fully1cl f
Neurohumoral transmission in ans final fully1cl fNeurohumoral transmission in ans final fully1cl f
Neurohumoral transmission in ans final fully1cl f
 
Physiological salt solution - PSS
Physiological salt solution - PSSPhysiological salt solution - PSS
Physiological salt solution - PSS
 
Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology. Parasympathomimetics and parasympatholytics Pharmacology.
Parasympathomimetics and parasympatholytics Pharmacology.
 
Parasympatholytic drugs
Parasympatholytic drugsParasympatholytic drugs
Parasympatholytic drugs
 
Expt 12 Anticonvulsant effect of drugs by MES and PTZ method
Expt 12 Anticonvulsant effect of drugs by MES and PTZ methodExpt 12 Anticonvulsant effect of drugs by MES and PTZ method
Expt 12 Anticonvulsant effect of drugs by MES and PTZ method
 
Expt. 1 Introduction to in vitro pharmacology and physiological salt solutions
Expt. 1 Introduction to in vitro pharmacology and physiological salt solutionsExpt. 1 Introduction to in vitro pharmacology and physiological salt solutions
Expt. 1 Introduction to in vitro pharmacology and physiological salt solutions
 
Effect of drugs on frog's heart perfusion
Effect of drugs on frog's heart perfusionEffect of drugs on frog's heart perfusion
Effect of drugs on frog's heart perfusion
 
Pharmacology (effects of drugs on the ciliary motility of forg oesophagus)
Pharmacology (effects of drugs on the ciliary motility of forg oesophagus)Pharmacology (effects of drugs on the ciliary motility of forg oesophagus)
Pharmacology (effects of drugs on the ciliary motility of forg oesophagus)
 
Commonly used instruments in Experimental Pharmacology
Commonly used instruments in Experimental Pharmacology Commonly used instruments in Experimental Pharmacology
Commonly used instruments in Experimental Pharmacology
 
Organization of ans
Organization of ansOrganization of ans
Organization of ans
 
Protein binding of drug.ppt
Protein binding of drug.pptProtein binding of drug.ppt
Protein binding of drug.ppt
 
Seminar on parasympathomimetic and parasympatholytic converted
Seminar on parasympathomimetic and parasympatholytic convertedSeminar on parasympathomimetic and parasympatholytic converted
Seminar on parasympathomimetic and parasympatholytic converted
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
 
Parasympathomimetics medicinal chemistry b. pharm.
Parasympathomimetics   medicinal chemistry    b. pharm. Parasympathomimetics   medicinal chemistry    b. pharm.
Parasympathomimetics medicinal chemistry b. pharm.
 
Neurohumoral transission in CNS
Neurohumoral transission in CNSNeurohumoral transission in CNS
Neurohumoral transission in CNS
 
SUBSTANCE P by RAGHUL PHARMACIST.
SUBSTANCE P by RAGHUL PHARMACIST.SUBSTANCE P by RAGHUL PHARMACIST.
SUBSTANCE P by RAGHUL PHARMACIST.
 

Similaire à NEUROHUMORAL TRANSMISSION

Neurohumoral Transmission.pptx
Neurohumoral Transmission.pptxNeurohumoral Transmission.pptx
Neurohumoral Transmission.pptxIkramMuhammad10
 
Neurotransmitters/General aspect and steps involved in neurotransmission.pptx
Neurotransmitters/General aspect and steps involved in neurotransmission.pptxNeurotransmitters/General aspect and steps involved in neurotransmission.pptx
Neurotransmitters/General aspect and steps involved in neurotransmission.pptxSIRAJUDDIN MOLLA
 
Ans introduction
Ans introductionAns introduction
Ans introductionAman9001
 
NEUROTRANSMITTER IN AUTONOMIC NERVOUS SYSTEM (1).pptx
NEUROTRANSMITTER IN AUTONOMIC NERVOUS SYSTEM (1).pptxNEUROTRANSMITTER IN AUTONOMIC NERVOUS SYSTEM (1).pptx
NEUROTRANSMITTER IN AUTONOMIC NERVOUS SYSTEM (1).pptxAttiqUrRehman98
 
Neurohumoral_transmission_pharmacology_of_neurotransmission
Neurohumoral_transmission_pharmacology_of_neurotransmissionNeurohumoral_transmission_pharmacology_of_neurotransmission
Neurohumoral_transmission_pharmacology_of_neurotransmissionSuman Bhattarai
 
Neurophysiology1
Neurophysiology1Neurophysiology1
Neurophysiology1Essy Essy
 
3. synapse 08-09
3. synapse 08-093. synapse 08-09
3. synapse 08-09Nasir Koko
 
3. synapse 08-09
3. synapse 08-093. synapse 08-09
3. synapse 08-09Nasir Koko
 
Synapses by Dr Pandian M .
Synapses by Dr Pandian M .Synapses by Dr Pandian M .
Synapses by Dr Pandian M .Pandian M
 
Organization and function of ans
Organization and function of ansOrganization and function of ans
Organization and function of ansMangeshBansod2
 
Nervous system: Transmission from nerve to muscle
Nervous system: Transmission from nerve to muscleNervous system: Transmission from nerve to muscle
Nervous system: Transmission from nerve to muscleLEEXINYI19
 

Similaire à NEUROHUMORAL TRANSMISSION (20)

Neurotransmittors
Neurotransmittors Neurotransmittors
Neurotransmittors
 
Neurohumoral Transmission.pptx
Neurohumoral Transmission.pptxNeurohumoral Transmission.pptx
Neurohumoral Transmission.pptx
 
Neurotransmitters/General aspect and steps involved in neurotransmission.pptx
Neurotransmitters/General aspect and steps involved in neurotransmission.pptxNeurotransmitters/General aspect and steps involved in neurotransmission.pptx
Neurotransmitters/General aspect and steps involved in neurotransmission.pptx
 
Nervous Syst
Nervous SystNervous Syst
Nervous Syst
 
Ans
AnsAns
Ans
 
Ans
AnsAns
Ans
 
Ans introduction
Ans introductionAns introduction
Ans introduction
 
NEUROTRANSMITTER IN AUTONOMIC NERVOUS SYSTEM (1).pptx
NEUROTRANSMITTER IN AUTONOMIC NERVOUS SYSTEM (1).pptxNEUROTRANSMITTER IN AUTONOMIC NERVOUS SYSTEM (1).pptx
NEUROTRANSMITTER IN AUTONOMIC NERVOUS SYSTEM (1).pptx
 
Neurohumoral_transmission_pharmacology_of_neurotransmission
Neurohumoral_transmission_pharmacology_of_neurotransmissionNeurohumoral_transmission_pharmacology_of_neurotransmission
Neurohumoral_transmission_pharmacology_of_neurotransmission
 
Nerve impulse transmission
Nerve impulse transmissionNerve impulse transmission
Nerve impulse transmission
 
Banin munir
Banin munirBanin munir
Banin munir
 
NHT- PHARMACOLOGY
 NHT- PHARMACOLOGY NHT- PHARMACOLOGY
NHT- PHARMACOLOGY
 
Neurophysiology1
Neurophysiology1Neurophysiology1
Neurophysiology1
 
3. synapse 08-09
3. synapse 08-093. synapse 08-09
3. synapse 08-09
 
3. synapse 08-09
3. synapse 08-093. synapse 08-09
3. synapse 08-09
 
Synapses by Dr Pandian M .
Synapses by Dr Pandian M .Synapses by Dr Pandian M .
Synapses by Dr Pandian M .
 
Neurotransmission
NeurotransmissionNeurotransmission
Neurotransmission
 
Organization and function of ans
Organization and function of ansOrganization and function of ans
Organization and function of ans
 
Nervous system: Transmission from nerve to muscle
Nervous system: Transmission from nerve to muscleNervous system: Transmission from nerve to muscle
Nervous system: Transmission from nerve to muscle
 
Ch05
Ch05Ch05
Ch05
 

Plus de Heena Parveen

Bioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , OxytocinBioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , OxytocinHeena Parveen
 
Bioassay of insulin & Bioassay of Vasopressin
Bioassay of insulin & Bioassay of VasopressinBioassay of insulin & Bioassay of Vasopressin
Bioassay of insulin & Bioassay of VasopressinHeena Parveen
 
Bioassay ,its types for theory & practical
Bioassay ,its types for theory & practicalBioassay ,its types for theory & practical
Bioassay ,its types for theory & practicalHeena Parveen
 
Neuromuscular blockers &; skeletal muscle relaxants
Neuromuscular blockers &; skeletal muscle relaxantsNeuromuscular blockers &; skeletal muscle relaxants
Neuromuscular blockers &; skeletal muscle relaxantsHeena Parveen
 
Sympathomimetics / ADRENERGICS / SYMPATHOLYTICS
Sympathomimetics / ADRENERGICS / SYMPATHOLYTICSSympathomimetics / ADRENERGICS / SYMPATHOLYTICS
Sympathomimetics / ADRENERGICS / SYMPATHOLYTICSHeena Parveen
 
Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...
Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...
Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...Heena Parveen
 
NEUROTRANSMITTERS & RECEPTORS IN ANS
NEUROTRANSMITTERS & RECEPTORS IN ANS NEUROTRANSMITTERS & RECEPTORS IN ANS
NEUROTRANSMITTERS & RECEPTORS IN ANS Heena Parveen
 
Dose response relationship
Dose response relationshipDose response relationship
Dose response relationshipHeena Parveen
 
Dose response relationship
Dose response relationshipDose response relationship
Dose response relationshipHeena Parveen
 
FACTORS MODIFYING DRUG ACTION
FACTORS MODIFYING DRUG ACTIONFACTORS MODIFYING DRUG ACTION
FACTORS MODIFYING DRUG ACTIONHeena Parveen
 
Types of receptor signal transduction pathways
Types of receptor signal transduction pathwaysTypes of receptor signal transduction pathways
Types of receptor signal transduction pathwaysHeena Parveen
 
Drug discovery & clinical evaluation of new drugs
Drug discovery & clinical evaluation of new drugsDrug discovery & clinical evaluation of new drugs
Drug discovery & clinical evaluation of new drugsHeena Parveen
 
Pharmacokinetics absorption,distribution,metabolism,excretion
Pharmacokinetics  absorption,distribution,metabolism,excretionPharmacokinetics  absorption,distribution,metabolism,excretion
Pharmacokinetics absorption,distribution,metabolism,excretionHeena Parveen
 
Animal laboratory care and ethical requirements
Animal laboratory care and ethical requirementsAnimal laboratory care and ethical requirements
Animal laboratory care and ethical requirementsHeena Parveen
 
Pharmacology I receptor
Pharmacology I   receptorPharmacology I   receptor
Pharmacology I receptorHeena Parveen
 

Plus de Heena Parveen (20)

NSAID'S --ASPIRIN
NSAID'S --ASPIRINNSAID'S --ASPIRIN
NSAID'S --ASPIRIN
 
NSAID'S
NSAID'SNSAID'S
NSAID'S
 
Bioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , OxytocinBioassay of Digitalis, d-tubocurarine , Oxytocin
Bioassay of Digitalis, d-tubocurarine , Oxytocin
 
Bioassay of insulin & Bioassay of Vasopressin
Bioassay of insulin & Bioassay of VasopressinBioassay of insulin & Bioassay of Vasopressin
Bioassay of insulin & Bioassay of Vasopressin
 
Bioassay ,its types for theory & practical
Bioassay ,its types for theory & practicalBioassay ,its types for theory & practical
Bioassay ,its types for theory & practical
 
Neuromuscular blockers &; skeletal muscle relaxants
Neuromuscular blockers &; skeletal muscle relaxantsNeuromuscular blockers &; skeletal muscle relaxants
Neuromuscular blockers &; skeletal muscle relaxants
 
Sympathomimetics / ADRENERGICS / SYMPATHOLYTICS
Sympathomimetics / ADRENERGICS / SYMPATHOLYTICSSympathomimetics / ADRENERGICS / SYMPATHOLYTICS
Sympathomimetics / ADRENERGICS / SYMPATHOLYTICS
 
Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...
Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...
Parasympathomimetcs ; Cholinomimetics , Parasympathomimetics ;Anti-Choliester...
 
NEUROTRANSMITTERS & RECEPTORS IN ANS
NEUROTRANSMITTERS & RECEPTORS IN ANS NEUROTRANSMITTERS & RECEPTORS IN ANS
NEUROTRANSMITTERS & RECEPTORS IN ANS
 
Dose response relationship
Dose response relationshipDose response relationship
Dose response relationship
 
Dose response relationship
Dose response relationshipDose response relationship
Dose response relationship
 
FACTORS MODIFYING DRUG ACTION
FACTORS MODIFYING DRUG ACTIONFACTORS MODIFYING DRUG ACTION
FACTORS MODIFYING DRUG ACTION
 
Typhoid fever
Typhoid feverTyphoid fever
Typhoid fever
 
Types of receptor signal transduction pathways
Types of receptor signal transduction pathwaysTypes of receptor signal transduction pathways
Types of receptor signal transduction pathways
 
Drug discovery & clinical evaluation of new drugs
Drug discovery & clinical evaluation of new drugsDrug discovery & clinical evaluation of new drugs
Drug discovery & clinical evaluation of new drugs
 
Transfer pricing
Transfer pricingTransfer pricing
Transfer pricing
 
Pharmacokinetics absorption,distribution,metabolism,excretion
Pharmacokinetics  absorption,distribution,metabolism,excretionPharmacokinetics  absorption,distribution,metabolism,excretion
Pharmacokinetics absorption,distribution,metabolism,excretion
 
Receptors types
Receptors typesReceptors types
Receptors types
 
Animal laboratory care and ethical requirements
Animal laboratory care and ethical requirementsAnimal laboratory care and ethical requirements
Animal laboratory care and ethical requirements
 
Pharmacology I receptor
Pharmacology I   receptorPharmacology I   receptor
Pharmacology I receptor
 

Dernier

Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 

Dernier (20)

Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 

NEUROHUMORAL TRANSMISSION

  • 1. NEURO-HUMORAL TRANSMISSION PRESENTED BY: HEENA PARVEEN, M.PHARMACOLOGY, ASST.PROFESSOR.
  • 2. NEURO-HUMORAL TRANSMISSION Neurohumoral transmission implies that nerves transmit their message across synapses and neuro-effector junctions by the release of humoral chemical) messengers. Junctional transmission was thought to be electrical (it does occur in some lower animals and probably in certain areas of mammalian brain) but observations at the turn of last century prompted Elliott (1905) to suggest that sympathetic nerves functioned by the release of an adrenaline-like substance, and Dixon (1907) to propose that vagus released a muscarine like chemical. Otto Loewi (1921) provided direct proof of humoral transmission by perfusing two frog hearts in series. Stimulation of vagus nerve of the first heart caused arrest of both.
  • 3. To be considered as a postjunctionally acting neurohumoral transmitter a substance must fulfill the following criteria: It should be present in the presympathetic neuron (usually along with enzymes synthesizing it). It should be released in the medium following nerve stimulation. Its application should produce responses identical to those produced by nerve stimulation. Its effects should be antagonized or potentiated by other substances which similarlv alter effects of nerve stimulation.
  • 4. Steps in neurohumoral transmission:
  • 5. 1. lmpulse conduction : The resting transmembrane potential (-70 mV) is established by high K* permeability of axonal membrane and high axoplasmic concentration of this ion coupled with low Na* permeabilitv and its active extrusion from the neuron stimulation or arrival of an electrical impulse causes a sudden increase in Na* conductance depolarization and overshoot (reverse polarization, inside becoming 20 mV positive); K* ions then move out in the direction of their concentration gradient & repolarisation occurs. Ionic distribution is normalized during the refractory period by the activation of Na* K* pump. The action potential (AP) thus generated sets up local circuit currents which activate ionic channels at the next excitable part of the membrane (next node of Ranvier in myelinated nerve) and the AP is propagated without decrement.
  • 6. 2.Transmitter release: The transmitter (excitory or inhibitory) is stored in prejunctional nerve endings within sympathetic vesicles. Nerve impulse promotes fusion of vesicular and neuronal membranes through Ca+2 entry which fluidizes membranes. All contents of the vesicle transmitter, enzymes and other proteins) are extruded (exocytosis) in the junctional cleft. The release process can be modulated by the transmitter itself and by other agents through activation of specific receptors located on the prejunctional membrane. Example : Noradrenaline (NA) release is inhibited by NA (receptor), dopamine, adenosine, prostaglandins and enkephalins while isoprenaline (B2 receptor) and angiotensin AT1 receptor) increase NA release.
  • 7. 3.Transmitter action on postiunctional membrane: The released transmitter combines with specific receptors on the postjunctional membrane and depending on its nature induces an excitatory postsynaptic potential (EPSP) or an inhibitory postsynaptic potential (IPSP). EPSP : Increase in permeability to all cations -> Na* or Ca2* influx (through fast or slow channels) causes depolarization followed by K* efflux. These ionic movements are passive as the flow is down the concentration gradients. IPSP : Increase in permeability to smaller ions, i.e. K* and Cl- (hydrated K+ ion is smaller than hydrated Na* ion) only, so that K* moves out and Cl- moves in (in the direction of their concentration gradients) resulting in hyperpolarisation.
  • 8. 4. Postjunctional activity: A suprathreshold EPSP generates a propagated postjunctional AP which results in nerve impulse (in neurone), contraction (in muscle) or secretion (in gland). An IPSP stabilizes the postjunctional membrane and resists depolarizing stimuli. 5. Termination of transmitter action : Following its combination with the receptor, the transmitter is either locally degraded (e.g. ACh) or is taken back into the prejunctional neurone by active uptake or diffuses away (e.g. NA,GABA).
  • 9. Specific carrier proteins like norepinephrine transporter (NET), dopamine transporter (DAT), serotonin transporter (SERT) are expressed on the axonal membrane for this purpose. The rate of termination of transmitter action governs the rate at which responses can be transmitted across a junction (1 to 1000/sec).
  • 10. Co-Transmission It has now become apparent that the classical one neuron one transmitter' model is an over simplification. Most peripheral and central neurons have been shown to release more than one active substance when stimulated. In the ANS, besides the primary transmitters ACh and NA, neurons have been found to elaborate purines (ATP, adenosine), peptides (vasoactive intestinal peptide or VIP, neuropeptide-Y or NPY, substance P, enkephalins, somatostatin, etc.), nitric oxide and prostaglandins as co-transmitters. In most autonomic cholinergic neurons VIP is associated with ACh, while ATP is associated with both Ach and NA.
  • 11. Vascular adrenergic nerves contain NPY which causes long lasting vasoconstriction. The co-transmitter is stored in the same neuron but in distinct synaptic vesicles or locations. However, ATP is stored with NA in the same vesicle. On being released by the nerve impulse it may serve to regulate the presynaptic release of the primary transmitter and,/or postsynaptic sensitivity to it (neuromodulator role). The co-transmitter may also serve as an alternative transmitter in its own right and/or exert a trophic influence on the sympathetic structures
  • 12. Nonadrenergic, noncholinergic (NANC) transmission has been demonstrated in the autonomic innervation of the gut, vas deferens, urinary tract, salivary glands and certain blood vessels, where nerve stimulation is able to evoke limited responses even in the presence of total adrenergic and cholinergic blockade. For example, it has been shown that stimulation of sympathetic nerve to guinea pig vas deferens elicits a biphasic contractile response, the initial short-lasting phase of which is mediated by ATP (through P2 receptors) and the second longer lasting phase by NA (through u1 receptors). Many anomalous findings have been explained by the revelation of cotransmission.
  • 13.